prof. dr. Liv Veldeman
- Work address
-
C. Heymanslaan 10, ingang 98 - verdieping 1
9000 Gent - Liv.Veldeman@UGent.be
- ORCID iD
-
0000-0002-0995-2687
Show
Sort by
-
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
-
- Journal Article
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
-
- Journal Article
- open access
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
-
Predicting patient-reported symptom clusters in prostate cancer patients : a machine learning approach
-
- Journal Article
- A1
- open access
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
-
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
-
- Journal Article
- A2
- open access
Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort
-
- Journal Article
- A1
- open access
Four irradiation and three positioning techniques for whole breast radiotherapy : is sophisticated always better?
-
Application of frozen Thiel-embalmed specimens for radiotherapy delineation guideline development : a method to create accurate MRI-enhanced CT datasets